Product NDC: | 55150-173 |
Proprietary Name: | Sumatriptan |
Non Proprietary Name: | Sumatriptan |
Active Ingredient(s): | 6 mg/.5mL & nbsp; Sumatriptan |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55150-173 |
Labeler Name: | AuroMedics Pharma LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202758 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130423 |
Package NDC: | 55150-173-01 |
Package Description: | 5 VIAL, SINGLE-DOSE in 1 CARTON (55150-173-01) > .5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55150-173-01 |
Proprietary Name | Sumatriptan |
Package Description | 5 VIAL, SINGLE-DOSE in 1 CARTON (55150-173-01) > .5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55150-173 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sumatriptan |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20130423 |
Marketing Category Name | ANDA |
Labeler Name | AuroMedics Pharma LLC |
Substance Name | SUMATRIPTAN SUCCINATE |
Strength Number | 6 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |